KindlyMD, Inc. (NASDAQ:NAKA) Receives $30.00 Consensus Target Price from Brokerages

KindlyMD, Inc. (NASDAQ:NAKAGet Free Report) has received an average recommendation of “Hold” from the five research firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $30.00.

Several equities analysts have recently commented on NAKA shares. Weiss Ratings upgraded KindlyMD from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. Maxim Group cut their target price on KindlyMD from $60.00 to $30.00 and set a “buy” rating for the company in a research report on Monday, April 6th. Wall Street Zen raised KindlyMD to a “sell” rating in a research note on Saturday, May 23rd. Finally, TD Cowen started coverage on KindlyMD in a report on Friday, April 10th. They issued a “buy” rating and a $40.00 price target on the stock.

View Our Latest Stock Report on KindlyMD

Insider Activity

In related news, CEO David F. Bailey acquired 55,115 shares of KindlyMD stock in a transaction dated Thursday, May 28th. The shares were purchased at an average price of $5.62 per share, for a total transaction of $309,746.30. Following the completion of the transaction, the chief executive officer directly owned 3,175,476 shares in the company, valued at approximately $17,846,175.12. This represents a 1.77% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have purchased a total of 191,448 shares of company stock worth $992,908 in the last quarter. Company insiders own 24.49% of the company’s stock.

Hedge Funds Weigh In On KindlyMD

Institutional investors have recently bought and sold shares of the stock. Osaic Holdings Inc. purchased a new stake in KindlyMD in the 2nd quarter worth $215,000. Geode Capital Management LLC grew its position in shares of KindlyMD by 76.2% during the second quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock valued at $484,000 after purchasing an additional 8,386 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of KindlyMD by 1,638.4% in the third quarter. Tower Research Capital LLC TRC now owns 33,152 shares of the company’s stock worth $827,000 after purchasing an additional 31,245 shares during the last quarter. Victory Capital Management Inc. bought a new stake in shares of KindlyMD in the third quarter worth about $1,007,000. Finally, Sagespring Wealth Partners LLC purchased a new stake in shares of KindlyMD in the fourth quarter worth about $28,000.

KindlyMD Price Performance

Shares of NAKA stock opened at $4.80 on Friday. KindlyMD has a one year low of $3.33 and a one year high of $659.20. The company’s fifty day moving average price is $4.83 and its 200-day moving average price is $9.12. The company has a market capitalization of $83.52 million, a price-to-earnings ratio of -0.11 and a beta of 16.05.

KindlyMD (NASDAQ:NAKAGet Free Report) last issued its earnings results on Wednesday, May 13th. The company reported ($0.38) earnings per share for the quarter. KindlyMD had a negative return on equity of 81.32% and a negative net margin of 7,397.12%.The firm had revenue of $2.68 million during the quarter. Equities research analysts expect that KindlyMD will post -16.8 earnings per share for the current fiscal year.

About KindlyMD

(Get Free Report)

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.

Featured Articles

Analyst Recommendations for KindlyMD (NASDAQ:NAKA)

Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.